Affinity Biologicals Overview
- Year Founded
-
1987
- Status
-
Acquired/Merged
- Employees
-
31
- Latest Deal Type
-
M&A
Affinity Biologicals General Information
Description
Developer of products used worldwide in thrombosis and hemostasis research and medical diagnostics. The company's product line includes an extensive line of antibodies to coagulation and hemostasis-related proteins, conjugates, antibody pairs for immunoassay of human and animal analytes, ELISA kits, and a full line of human plasma products including immune-depleted plasmas, calibrators, and controls, along with services such as protein purification, antibody production, assay development, custom manufacturing, and lyophilization.
Contact Information
Website
www.affinitybiologicals.com(Operating Subsidiary)
Corporate Office
- 1348 Sandhill Drive
- Ancaster, Ontario L9G 4V5
- Canada
Corporate Office
- 1348 Sandhill Drive
- Ancaster, Ontario L9G 4V5
- Canada
Affinity Biologicals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Nov-2018 | Completed | Generating Revenue | |||
| 1. Seed Round | 22-Jun-2011 | Completed | Generating Revenue |
Affinity Biologicals Comparisons
Industry
Financing
Details
Affinity Biologicals Competitors (3)
One of Affinity Biologicals’s 3 competitors is BioPharm Laboratories, a Formerly VC-backed company based in Bluffdale, UT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioPharm Laboratories | Formerly VC-backed | Bluffdale, UT | ||||
| R 2 Diagnostics | Corporation | South Bend, IN | ||||
| ProteoGenex | Corporation | Inglewood, CA |
Affinity Biologicals Patents
Affinity Biologicals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-6432658-B1 | Anticoagulants and calcium ions | Inactive | 13-Sep-2000 | ||
| AU-2001291553-A1 | Method for measuring antithrombin activity | Inactive | 13-Sep-2000 | ||
| CA-2421957-A1 | Method for measuring antithrombin activity | Active | 13-Sep-2000 | ||
| CA-2421957-C | Method for measuring antithrombin activity | Inactive | 13-Sep-2000 | ||
| EP-1317671-A2 | Method for measuring antithrombin activity | Inactive | 13-Sep-2000 | G01N33/86 |
Affinity Biologicals Signals
Affinity Biologicals Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Foundation Venture Capital Group | Venture Capital | Minority |
Affinity Biologicals FAQs
-
When was Affinity Biologicals founded?
Affinity Biologicals was founded in 1987.
-
Where is Affinity Biologicals headquartered?
Affinity Biologicals is headquartered in Ancaster, Canada.
-
What is the size of Affinity Biologicals?
Affinity Biologicals has 31 total employees.
-
What industry is Affinity Biologicals in?
Affinity Biologicals’s primary industry is Drug Discovery.
-
Is Affinity Biologicals a private or public company?
Affinity Biologicals is a Private company.
-
What is Affinity Biologicals’s current revenue?
The current revenue for Affinity Biologicals is .
-
How much funding has Affinity Biologicals raised over time?
Affinity Biologicals has raised $500K.
-
Who are Affinity Biologicals’s investors?
Foundation Venture Capital Group has invested in Affinity Biologicals.
-
Who are Affinity Biologicals’s competitors?
BioPharm Laboratories, R 2 Diagnostics, and ProteoGenex are competitors of Affinity Biologicals.
-
When was Affinity Biologicals acquired?
Affinity Biologicals was acquired on 01-Nov-2018.
-
Who acquired Affinity Biologicals?
Affinity Biologicals was acquired by Precision BioLogic.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process